Tactic Pharmaceuticals acquires and develops pre-clinical and clinical stage compounds. Tactic currently has three development stage compounds in its portfolio: ATN-161, ATN-224, and ATN-658.
Contact Information
Tactic Pharma, LLC
1007 Church St.
Suite 307
Evanston, IL 60201
(847) 733-0940 info@tacticpharma.com